Table 5: ER/PR/Her-2-Neu status and MMP-2 activity of 36 patients.

Sl No Age Type of Carcinoma Stage ER PR Her-2-Neu MMP- 2 Activity
Pre Post
1. 61 Ductal I - - - 2.0 0
2. 50 Ductal I + + _ 2.0 0
3. 58 Ductal I +3 +3 0 2.0 0
4. 70 Ductal I - - -1 2.0 0
5. 35 Ductal II - - - 2.0 0
6. 47 Ductal II - - - 2.0 0
7. 36 Ductal II + _ _ 3.0 0
8. 47 Ductal II - - - 2.0 0
9. 60 Ductal II - - - 2.0 0
10. 47 Ductal II + - - 3.0 0
11. 52 Ductal II +3 +3 +3 3.0 0
12. 45 Ductal IIB + + _ 3.0 0
13. 64 Ductal II B NA NA NA 3.0 0
14. 60 Ductal II B 3+ 3+ -1 3.0 0
15. 55 Ductal II B 3+ 3+ -1 3.0 0
16. 65 Ductal II B NA NA NA 3.0 0
17. 50 Ductal IIB + + _ 3.0 0
18. 48 Ductal III + + + 4.0 0
19. 38 Ductal III - - - 4.0 0
20. 40 Ductal III _ - - 4.0 0
21. 46 Ductal III + + + 4.0 0
22. 53 Ductal III + + - 3.0 0
23. 58 Ductal III - - - 4.0 0
24. 40 Ductal III + + + 4.0 0
25. 57 Ductal III - - - 4.0 0
26. 50 Ductal III - - - 3.0 0
27. 48 Ductal III + + - 4.0 0
28. 55 Ductal III +3 +1 +3 4.0 0
29. 50 Ductal III + + + 4.0 0
30. 36 Ductal III A + + + 3.0 0
31. 33 Ductal III A - - - 4.0 0
32. 18 Invasive Lobular(hereditary) IIIC _ _ _ 4.0 0
33. 49 Ductal IV + + _ 5.0 0
34. 56 Ductal IV _ _ _ 5.0 0
35. 38 Ductal IV + + + 5.0 0
36. 32 Ductal IV + + + 5.0 0

ER/PR/Her-2 Neu status and comparative zymography of saliva (pre and post surgery) were done in 36 cases of same breast cancer patients at different stages. P < 0.05.
Comparative salivary MMP-2 activity of pre and post surgical cases of the same patients and the ER/PR/Her-2-neu status of 36 patients were listed in Table-5. The activity of MMP-2 was expressed as number of bands (lower mol. wt) the pro MMP-2(72 kD) was converted (being active) stagewise (I-IV).